Tagged with R

AKRIKHIN You took over this company in 2007, which was the pivotal year when a group of investors assumed control of Akrikhin and the main strategic investor was Polpharma. Since then, from 2007 to 2010, the company has more than tripled its turnover. It is now one of the top five…

Astellas Russia When our team interviewed Amit Makwana at Astellas’ European Headquarters in the UK, he noted that the Russian affiliate is experiencing a huge growth rate that is very difficult for the rest of the European business to keep up with. All eyes are on you. Do you feel the envy…

Janssen Serbia How does Janssen view the Serbian market today, and how has company built up its presence here in the country? Previously we were working through distribution channels and in 2003 we started to operate as a part of Johnson & Johnson in Serbia. As you know J&J has three parts:…

NATCO Pharma Compared to 5 years ago, MNCs have increased their presence in India. Some even have become market leaders, particularly through acquisitions of domestic players. How is this redistributing the game for local players? The Indian market structure is shaped in such way that no generic player gets big market shares.…

Novo Nordisk (Serbia) Novo Nordisk has a long history in Serbia compared to many of the other multinational companies present in the country today. The separate entity Novo Nordisk d.o.o was founded in 2006, but you have been present in the market for over 20 years. Given this history, how would you describe…

Association of European Businesses (AEB) The AEB works through a number of channels to promote the interests of European corporations with operations in Russia. It has a long history in this country, dating back to 1995. Why is a group like the AEB necessary, and what are the main targets on its agenda this year?…

Bharat Biotech International Limited If we first take a step back and look at how Bharat Biotech was established, we see quite a remarkable story. It is rather exceptional to see scientists becoming entrepreneurs. What made you this exception, and what drove you to set up Bharat Biotech? I was based in the US…

Reckitt Benckiser Russia & CIS Many expat managers have used Russia as a stepping-stone, but you have headed this business for an astounding 9 years. What is it about this country and about Reckitt Benckiser’s affiliate here that has prompted you to stay for so long? That is a good question—because in our company, we…

MSD pharmaceuticals Pvt. Ltd. While your appointment as Managing Director was not a long time ago, you immediately faced the big task to oversee one of the most complicated corporate mergers the local Indian drug industry has seen in recent years. How challenging was the integration of Fulford and Organon for you? One of…

Tapasya Engineering Works One trend we have seen taking place over the years is that, today, Indian machines are far better in quality and in par with international standards, than 15 years ago. How have you seen the Indian pharma machinery industry evolving over time, and where does it stand today? India is…

UCB Russia When we first met, you mentioned that you assumed this position in 2009, to help UCB Russia recover from a flat spin in the wake of the financial crisis. What areas did you specifically target for improvement, and how did you turn this affiliate around? The most significant issue that…

Ministry of Health Voivodeships, Polish expenditure on health care system per one resident is still below the European average. In regards to the issue concerning the „expenditure on health care system”, I would like to inform you that the financial plan of the National Health Fund for 2011 provides that costs of health…